Connected’s products will be available to Florida’s medical cannabis patients exclusively at Trulieve.
TALLAHASSEE, Fla., Jan. 18, 2022 – PRESS RELEASE – Trulieve Cannabis Corp., a leading and top-performing cannabis company in the U.S., announced an expanded partnership with Connected Cannabis Co., a premier cannabis cultivator. Through this agreement, Trulieve will be the exclusive producer, processor and retailer of Connected branded products throughout Florida.
Connected branded products will be available later this year exclusively at Trulieve’s 111 Florida dispensaries. Trulieve already partners with Connected in Arizona.
“Trulieve is excited about expanding our partnership with Connected as we continue seeking ways to benefit our patients,” Trulieve CEO Kim Rivers said. “Connected maintains a portfolio of proprietary top-shelf strains that our customers and patients desire in other markets, and we anticipate a similar response in Florida.”
Connected has been building a proprietary genetics portfolio of premium strains and meticulously cultivating cannabis at scale since 2009. With more than a decade of industry experience, Connected is known as a leading brand in the cannabis space and a pioneer in the industry.
“We’re proud to expand our successful partnership with Trulieve to bring our award-winning Connected and Alien Labs products to the East Coast,” Connected co-founder Caleb Counts said.
Sam Ghods, CEO of Connected, added, “We value their leadership as the top operator in the state and share their commitment to providing customers with the best products possible.”
As Florida’s first, largest and leading medical cannabis provider, Trulieve offers Florida’s largest selection of THC and CBD products in a variety of delivery methods, including edibles, smokable flower, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers statewide home delivery, convenient online ordering, and in-store pickup.
For more information, please visit www.connectedcannabisco.com and www.Trulieve.com.